Search bioRxivSearch

Biology subjects

De Toma, A.

Publications and source records attributed to De Toma, A..

2 recordsLinked to original sources

Dwarf-shrubs dynamics in Mediterranean high mountain ecosystems

QuestionVegetation in the alpine and treeline ecotone faces changes in both climate and land use. Shrub encroachment is considered an effect of these changes, but its still unclear how this effect is mediated by environmental heterogeneity. Our goal is to determine which environmental factors shape the fine-scale spatial distribution and temporal trends of alpine dwarf shrub. LocationThree sites in the Central Apennine, Italy. MethodsWe used a comprehensive set of environmental factors across a broad temporal span to model, at a fine-scale, both (1) the current spatial distribution and (2) the change in shrub cover over the past 60 years. ResultsOur results show that dwarf shrubs have generally increased in our study sites over the past 60 years, yet their distribution is strongly shaped by the joint influence of the fine-scale topography, productivity, land use and micro-climate. In particular, shrubs have been locally favored in areas with harsher alpine environmental constraints and stronger resource limitation. Instead, contrary to expectations, at this fine scale, warmer temperatures and the decline in grazing have not favored shrub encroachment. ConclusionDwarf shrubs appear as a stress-tolerant, pioneer vegetation that is currently distributed mainly over areas that are otherwise sparsely vegetated. It appears that shrubs exhibit poor competitive ability to invade grasslands and, though they have increased overall, they remain restricted to the least productive areas. Fine-scale environmental heterogeneity may strongly influence future responses of dwarf shrubs in changing alpine ecosystems.

ecology

SDF-1/CXCR4 inhibition prevents paradoxical generation of cisplatin-induced pro-metastatic niches

Platinum-based chemotherapy remains widely used in advanced non-small cell lung cancer (NSCLC) despite its ineffectiveness in long-term control of metastasis. Here, we uncover the interconnected pathways subtending cisplatin-induced metastasis promotion. We report that cisplatin treatment of tumor-free mice results in bone-marrow expansion of CCR2+CXCR4+Ly6Chigh inflammatory monocytes (IM) concomitantly with increased levels in the lungs of stromal SDF-1, the CXCR4 ligand. In experimental metastasis assays, cisplatin-induced IM favor tumor cells extravasation and expansion of CD133+CXCR4+ metastasis initiating cells (MICs), facilitating lung metastasis formation. At the primary tumor, cisplatin reduces tumor size but induces tumor release of SDF-1 triggering MICs expansion and recruitment of pro-invasive CXCR4+ macrophages. Co-recruitment of MICs and CCR2+CXCR4+ IM at SDF-1-enriched distant sites also promotes spontaneous metastasis. Combination treatment with a CXCR4 inhibitor prevents cisplatin-induced IM/MICs recruitment and interaction thus precluding metastasis overgrowth. Finally, we observe in NSCLC patients specimens that SDF-1 levels are higher in platinum-treated samples and correlate with worse outcome. Our findings suggest a possible novel combination therapy based on CXCR4 blockade to control metastatic disease, paradoxically promoted by cisplatin.

cancer biology